Crescent Diagnostics Ltd. (Crescent Diagnostics) is a medical device company engaged in the field of orthopedics, developing a new biomarker Bone Quality Test (BQT). It is conducting a range of clinical trials in partnership with hospitals in the UK and Ireland to expand the clinical evidence underlying this technology. The new biomarker uses Raman spectroscopy to analyze the human fingernail and assess bone health. It is useful for accurate prediction of bone fracture risk. Crescent Diagnostics has a comprehensive Intellectual Property portfolio covering the biomarker and its application. The company owns its research office at Limerick, Ireland. Crescent Diagnostics is headquartered at London, the UK.

Street: 
43 WELLINGTON ROW
City: 
London
Postcode: 
E2 7BB
Federal State : 
United Kingdom
WebSite: 
www.crescentds.com

Company Index Score

Current Index Score Historical Index Score
  • Crescent Diagnostics Ltd. currently scores 50 % in the index.
  • Crescent Diagnostics Ltd. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Crescent Diagnostics Ltd. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets